5
on chiral DAICEL CHIRALCEL OD-H or CHIRALPAK AD-H
6H), 0.78 (t, J = 7.5 Hz,6H); 13C NMR(100 MHz, CDCl3) δ
column. Optical rotations are measured on a commercial
78.6, 75.7,70.3, 68.2, 28.9, 28.7, 25.1, 21.4, 20.3, 8.0, 7.2. IR
(KBr): υ = 3673, 2968, 1487, 1462, 1143, 977 cm-1. HRMS (ESI,
M+H+) calcd. for C21H42N2O4, 387.3217; found 387.3220.
T
polarimeter and are reported as follows: [α] (c = g/100 mL,
D
solvent). Unless otherwise indicated, starting materials and
reagents used in the study were purchased and were used as
received without further purification.
4.2.4.
(1R,2S)-2-(3-hydroxy-2,4-dimethylpentan-3-yl)-1-(3-
((1R,2S)-2-(3-hydroxy-2,4-dimethylpentan-3-yl)-1-
4.2. Typical Procedure for the preparation of chiral ligands
1a-1e.22
oxidopyrrolidin-1-yl)propyl)pyrrolidine 1-oxide (1d)
Compound 1d was prepared according to the general
Amino alcohol 4b (1.07 g, 8.3 mmol) was added to a 100 mL
round-bottomed flask containing 50 mL acetonitrile, then 1,3-
dibromopropane (0.83 g, 4.2 mmol) and potassium carbonate
(3.50 g, 2.5 mmol) was slowly added portionwise to the flask
over 10 min. The mixture was stirred overnight at 95 °C, then
cooled to room temperature. The solvent was removed in vacuo,
water (20 mL) was added to the residue, and the mixture was
extracted with ethyl acetate (3 × 10 mL). The combined organic
phase was dried over Na2SO4, filtered and concentrated. The
obtained amino alcohol 5b was used without further purification.
procedure and was isolated as brown oil (56% yield) after flash
1
chromatography. [α]2D0 = -8.00 (c = 0.1, CHCl3); H NMR (400
◦
MHz, Chloroform-d, 25 C, TMS): δ=3.89 (dt, J = 13.9, 7.6 Hz,
2H), 3.54-3.26 (m, 8H), 2.62-2.53 (m, 2H), 2.46-2.22 (m, 7H),
2.05-1.72 (m, 7H), 1.10 (d, J = 6.6 Hz, 6H), 1.01 (d, J = 6.9 Hz,
6H), 0.92 (d, J = 6.6 Hz, 3H), 0.85 (d, J = 6.9 Hz, 6H); 13C
NMR(101 MHz, CDCl3) δ 78.7, 76.5, 69.7,68.2, 34.3, 32.4, 27.6,
22.5, 20.2, 19.3, 18.2, 17.9, 16.8. IR (KBr): υ = 3394, 2964,
1469, 1367, 1068, 942 cm-1. HRMS (ESI, M+H+) calcd. for
C25H50N2O4, 343.3843; found 343.3843.
To a solution of amino alcohol 5b (0.95 g, 3.2 mmol) in 15
mL dichloromethane, was added m-chloroperoxybenzoic acid
(1.61 g, 7.0 mmol). The mixture was stirred at room temperature
for 12 h, and the solvent was removed in vacuo to give the crude
product. Compound 1b was obtained in 80% (1.02 g) after
column chromatography through silica gel (ethyl acetate as
eluent).
4.2.5.
(1R,2S)-2-(hydroxydiphenylmethyl)-1-(3-((1R,2S)-2-
(hydroxydiphenylmethyl)-1-oxidopyrrolidin-1-
yl)propyl)pyrrolidine 1-oxide (1e)
Compound 1e was prepared according to the general procedure
and was isolated as brown solid (77% yield) after flash
◦
chromatography. mp: 212-216 C; [α]2D0 = 22.00 (c = 0.1, CHCl3);
1H NMR (400 MHz, Chloroform-d, 25 C, TMS): δ= 11.36 (s,
◦
4.2.1. (1R,1'R,2S,2'S)-1,1'-(propane-1,3-diyl)bis(2-(2-
hydroxypropan-2-yl)pyrrolidine 1-oxide) (1b).
2H), 7.71-7.61 (m, 4H), 7.56-7.43 (m, 4H), 7.33-7.22 (m, 10H),
7.18-7.09 (m, 2H), 4.22 (t, J = 9.0 Hz, 2H), 3.34 (t, J = 9.2 Hz,
2H), 3.23-3.08 (m, 2H), 2.55-2.17 (m, 7H), 2.17-2.03 (m, 2H),
2.00-1.86 (m, 2H), 1.86-1.77 (m, 2H), 1.77-1.65 (m, 1H). 13C
NMR (101 MHz, CDCl3) δ 147.3, 146.6, 128.2, 128.2, 126.8,
126.6, 125.9, 124.6, 77.8, 77.6, 68.7, 66.0, 26.1, 19.8, 19.5. IR
(KBr): υ = 3743, 2958, 1534, 1490, 689, 657 cm-1. HRMS (ESI,
M+H+) calcd. for C37H42N2O4, 579.3217; found 579.3213.
Compound 1b was prepared according to the general
procedure and was isolated as brown solid; mp: 130-138 °C; [α]D20
= -43.99 (c = 0.1, CHCl3); 1H NMR (400 MHz, Chloroform-d, 25
◦C, TMS): δ= 8.70 (s, 2H), 3.98-3.68 (m, 2H), 3.63-3.32 (m, 6H),
3.24 (t, J = 8.7 Hz, 2H), 2.62 (t, J = 7.3 Hz, 2H), 2.53-2.39 (m,
2H),2.33-2.19 (m, 2H), 2.13-1.98 (m, 2H), 1.95-1.76 (m, 2H),
1.50 (s, 6H), 1.23 (s, 6H). 13C NMR(101 MHz, CDCl3) δ 80.9,
71.2, 69.5, 67.7, 29.9, 28.2, 25.6, 21.3, 20.0. IR (KBr): υ = 3433,
2974, 1480, 1362, 962, 652 cm-1. HRMS (ESI, M+H+) calcd. for
C17H34N2O4 331.2591; found 331.2595.
Crystal data for 1e: C37H42N2O4, M = 578.72, a = 9.0796(2) ? b =
10.8989(2) Å c = 15.9762(3) ? α = 90°, β = 92.534(2)°, γ = 90°, V
= 1579.42(5) Å3, T = 298.80(10) K, space group P1211, Z = 2,
ꢀ(CuKα) = 0.622 mm-1, 8675 reflections measured, 4667
independent reflections (Rint = 0.0150). The final R1 values were
0.0355 (I > 2σ(I)). The final wR(F2) values were 0.0961 (I >
2σ(I)). The final R1 values were 0.0371 (all data). The final
wR(F2) values were 0.0980 (all data). The goodness of fit on F2
was 1.007. Flack parameter = -0.04(10). CCDC 1911346.
4.2.2.
(1R,1'R,2S,2'S)-1,1'-(propane-1,3-diyl)bis(2-
(hydroxymethyl)pyrrolidine 1-oxide) (1a)
Compound 1a was prepared according to the general
procedure and was isolated as brown oil (54% yield) after flash
1
chromatography. brown oil; [α]2D0 = -2.36 ; (c =0.1, MeOH); H
4.3. General procedure for asymmetric Henry reaction.
◦
NMR (400 MHz, Chloroform-d, 25 C, TMS): δ = 4.17 (d, J =
13.1 Hz, 2H), 3.87 (dd, J = 13.1, 4.4 Hz, 2H), 3.82-3.72 (m, 2H),
3.60-3.46 (m, 4H), 3.43-3.26 (m, 4H), 2.74-2.60(m, 2H), 2.58-
2.45 (m, 2H), 2.40-2.27 (m, 2H), 2.12-1.89 (m, 6H)ppm. 13C
NMR (101 MHz, DMSO) δ 74.7, 66.6, 63.2, 58.8, 8.7, 23.8,
20.2, 19.6. IR (KBr): υ = 3392, 2958, 1452, 1055, 734, 652 cm-1.
HRMS (ESI, M+H+) calcd. for C13H26N2O4 275.1965; found
275.1970.
A mixture of Ligand 1c (3.86 mg, 0.01 mmol, 10 mol%),
Cu(OAc)2 (1.8 mg, 0.01 mmol, 10 mol%) and 4 Å molecular
sieves (20 mg) was stirred in anhydrous chloroform and dioxane
(2.4/0.6 mL) at room temperature for 20 min to allow the
formation of the complex. Then nitromethane (61 mg, 1.0 mmol)
was added to the mixture. Nitrobenzaldehyde 6b (0.1 mmol) was
then added and the mixture was stirred for 48 h. The reaction
mixture was purified by column chromatography through silica
gel (petroleum ether/ethyl acetate = 8:1) to afford the nitroaldol
product 7b (11.8 mg, 66% yield) as a colourless oil. Chiralcel
OD-H hexane/i-PrOH. 85:15, 1.0 mL/min, R : tr(minor) = 15.9
min, S: tr(major) = 19.9 min; 1H NMR (400 MHz, Chloroform-d,
TMS): δ= 8.33-8.22 (m, 2H), 7.67-7.61 (m, 2H), 5.67-5.55 (m,
1H), 4.64-4.53 (m, 2H), 3.17 (s, 1H) ppm.
4.2.3. (1R,2S)-2-(3-hydroxypentan-3-yl)-1-(3-((1R,2S)-2-(3-
hydroxypentan-3-yl)-1-oxidopyrrolidin-1-yl)propyl)pyrrolidine
1-oxide) (1c)
Compound 1c was prepared according to the general
procedure and was isolated as brown solid (78% yield) after flash
chromatography. mp: 165-168 ◦C; [α]D20 = -27.86 (c = 0.1, CHCl3);
◦
1H NMR (400 MHz, Chloroform-d, 25 C, TMS): δ= 8.53 (s,
5. Appendix A. Supplementary data
2H), 3.86-3.68 (m, 2H), 3.55-3.44 (m, 2H), 3.40 (dd, J = 7.9, 6.1
Hz, 4H), 3.26 (t, J = 8.8 Hz, 1H), 2.63-2.46 (m, 4H), 2.31-2.17
(m, 2H), 2.15-2.03 (m, 2H), 2.02-1.89 (m, 2H), 1.86-1.73 (m,
4H), 1.70-1.57 (m, 2H), 1.37-1.25 (m, 2H), 0.90 (t, J = 7.4 Hz,
Supplementary data related to this article can be found at
http://dx.doi.org/10.1016/j.tet.2018.XX.XXX.